Literature DB >> 7697219

Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus.

A Lernmark1, G Klöppel, D Stenger, C Vathanaprida, K Fält, M Landin-Olsson, D G Baskin, J P Palmer, A M Gown, J S Petersen.   

Abstract

The mechanisms by which the beta cells of pancreatic islets are destroyed in insulin-dependent diabetes mellitus (IDDM) are poorly understood. In this report the pancreatic histo- and immunopathology of two children, both HLA-DR 3/4, DQ 2/8 positive and who both died from cerebral oedema within a day of clinical diagnosis of IDDM, were investigated. Patient 1, a 14-month-old girl, had a 4-week history of polydipsia and polyuria. Patient 2, a 3-year-old boy, had 2 days of illness. Both patients had a similarly severe loss of insulin cells but differed markedly as to the extent of lymphocytic islet infiltration (insulitis). Apart from insulitis, marked islet macrophage infiltration was demonstrated in both patients with the HAM-56 monoclonal antibody. Neither patient showed aberrant expression of HLA class II antigens on insulin-immunoreactive cells, but allele-specific HLA-DQ8 expression was evident on endothelial cells. Glutamic acid decarboxylase immunoreactivity was detected in both insulin- and glucagon-immunoreactive cells. It is concluded that the heterogeneity of islet pathology, especially insulitis, may reflect different dynamics and extent rather than different pathomechanisms of immune destruction of islets in IDDM.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697219     DOI: 10.1007/bf00199353

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  55 in total

1.  The Pathology of Diabetes, with Special Reference to Pancreatic Regeneration.

Authors:  S Warren; H F Root
Journal:  Am J Pathol       Date:  1925-07       Impact factor: 4.307

2.  Intracerebral crises during treatment of diabetic ketoacidosis.

Authors:  A L Rosenbloom
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

3.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

4.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

5.  Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes.

Authors:  G Klöppel; C R Drenck; M Oberholzer; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

6.  A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.

Authors:  W J Riley; N K Maclaren; J Krischer; R P Spillar; J H Silverstein; D A Schatz; S Schwartz; J Malone; S Shah; C Vadheim
Journal:  N Engl J Med       Date:  1990-10-25       Impact factor: 91.245

7.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

8.  Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M L Olsson; G Sundkvist; A Lernmark
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

9.  Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.

Authors:  H Bärmeier; D K McCulloch; J L Neifing; G Warnock; R V Rajotte; J P Palmer; A Lernmark
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

10.  Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.

Authors:  E Bonifacio; P J Bingley; M Shattock; B M Dean; D Dunger; E A Gale; G F Bottazzo
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  18 in total

1.  Mast cells infiltrate pancreatic islets in human type 1 diabetes.

Authors:  Luisa Martino; Matilde Masini; Marco Bugliani; Lorella Marselli; Mara Suleiman; Ugo Boggi; Tatiane C Nogueira; Franco Filipponi; Margherita Occhipinti; Daniela Campani; Francesco Dotta; Farooq Syed; Decio L Eizirik; Piero Marchetti; Vincenzo De Tata
Journal:  Diabetologia       Date:  2015-08-15       Impact factor: 10.122

Review 2.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

3.  Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment.

Authors:  K Sayama; A Imagawa; K Okita; S Uno; M Moriwaki; J Kozawa; H Iwahashi; K Yamagata; S Tamura; Y Matsuzawa; T Hanafusa; J Miyagawa; I Shimomura
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

4.  Older age of childhood type 1 diabetes onset is associated with islet autoantibody positivity >30 years later: the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  R G Miller; L Yu; D J Becker; T J Orchard; T Costacou
Journal:  Diabet Med       Date:  2020-02-11       Impact factor: 4.359

Review 5.  Islet cell neogenesis in the pancreas.

Authors:  L Bouwens; G Klöppel
Journal:  Virchows Arch       Date:  1996-03       Impact factor: 4.064

Review 6.  Insulitis in human type 1 diabetes: The quest for an elusive lesion.

Authors:  Peter In't Veld
Journal:  Islets       Date:  2011-07-01       Impact factor: 2.694

7.  Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter].

Authors:  Martha L Campbell-Thompson; Desmond A Schatz; John S Kaddis; Mark A Atkinson
Journal:  Diabetologia       Date:  2016-02-09       Impact factor: 10.122

8.  HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes.

Authors:  Mark A Russell; Sambra D Redick; David M Blodgett; Sarah J Richardson; Pia Leete; Lars Krogvold; Knut Dahl-Jørgensen; Rita Bottino; Marcela Brissova; Jason M Spaeth; Jenny Aurielle B Babon; Rachana Haliyur; Alvin C Powers; Chaoxing Yang; Sally C Kent; Alan G Derr; Alper Kucukural; Manuel G Garber; Noel G Morgan; David M Harlan
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

9.  Insulin-Dependent Diabetes Mellitus: Islet Changes in Relation to Etiology and Pathogenesis.

Authors:  Gunter Kloppel; Andreas Clemens
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

10.  Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.

Authors:  Shoichiro Tanaka; Yoriko Nishida; Kaoru Aida; Taro Maruyama; Akira Shimada; Masako Suzuki; Hiroki Shimura; Soichi Takizawa; Masashi Takahashi; Daiichiro Akiyama; Sayaka Arai-Yamashita; Fumihiko Furuya; Akio Kawaguchi; Masahiro Kaneshige; Ryohei Katoh; Toyoshi Endo; Tetsuro Kobayashi
Journal:  Diabetes       Date:  2009-07-29       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.